Ovid Therapeutics appointed Kevin Norrett as chief business officer to lead business and corporate development functions and strategic partnerships. Norrett previously served as chief business officer at Soleno Therapeutics. The company also promoted Charles Carter to chief financial officer, succeeding Jeffrey Rona who will remain a long-term advisor through 2027, and promoted Victoria Fort to chief strategy officer overseeing enterprise strategy, investor relations, and operational growth initiatives.
Ovid Therapeutics IncAppointment of new CBO and promotions of CFO and CSO signal strengthened leadership and strategic focus.
Soleno Therapeutics Inc